Diabetes Prevention - Immune Tolerance

NCT01122446 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Prediabetes
Type 1 Diabetes

Interventions

OTHER: Placebo comparator
DRUG: Diamyd

Sponsor

Lund University

Collaborators

[object Object]